AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 48 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,541 | +25.5% | 1,440 | +58.6% | 0.00% | 0.0% |
| Q2 2023 | $15,572 | +28212.7% | 908 | -66.4% | 0.00% | -50.0% |
| Q1 2023 | $55 | +61.8% | 2,702 | +136.2% | 0.00% | +100.0% |
| Q4 2022 | $34 | -99.9% | 1,144 | -66.8% | 0.00% | 0.0% |
| Q3 2022 | $57,000 | +612.5% | 3,449 | +569.7% | 0.00% | – |
| Q2 2022 | $8,000 | -69.2% | 515 | -63.7% | 0.00% | – |
| Q1 2022 | $26,000 | -29.7% | 1,418 | -54.6% | 0.00% | -100.0% |
| Q4 2021 | $37,000 | +311.1% | 3,124 | +654.6% | 0.00% | – |
| Q3 2021 | $9,000 | +80.0% | 414 | +76.2% | 0.00% | – |
| Q2 2021 | $5,000 | – | 235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $17,690,227 | 28.88% |
| Atlas Venture Life Science Advisors, LLC | 2,017,521 | $59,113,365 | 7.12% |
| Sofinnova Investments, Inc. | 3,758,686 | $110,129,500 | 6.54% |
| TCG Crossover Management, LLC | 1,081,274 | $31,681,328 | 5.59% |
| RA Capital Management | 8,263,982 | $242,134,673 | 4.91% |
| Cormorant Asset Management, LP | 1,957,132 | $57,344 | 3.84% |
| VR Adviser, LLC | 747,869 | $21,912,562 | 3.69% |
| Octagon Capital Advisors LP | 621,712 | $18,216,162 | 2.84% |
| GREAT POINT PARTNERS LLC | 378,522 | $11,090,695 | 2.17% |
| Ghost Tree Capital, LLC | 135,000 | $3,956,000 | 1.69% |